Free Case Evaluations — Call 24/7
Call Us
Free Case Evaluations — Call 24/7
Free Case Evaluations — Call 24/7
Legal Services
Legal Services
Free Case Evaluations — Call 24/7
About Us
About Us
Live Chat

Zantac Injury Lawyers


Multiple lawsuits have been filed against manufacturers of Zantac. Plaintiffs allege that the drugmakers Sanofi and Boerhinger Ingelheim manufactured, marketed and sold a product they knew or reasonably should have known, was contaminated with a known carcinogen.

Multiple lawsuits have been filed against manufacturers of Zantac. Plaintiffs allege that the drugmakers Sanofi and Boerhinger Ingelheim manufactured, marketed and sold a product they knew or reasonably should have known, was contaminated with a known carcinogen.

Breaking News

On April 1, 2020 the FDA requested that manufacturers pull all over-the-counter and prescription ranitidine medicines, known by brand name Zantac, from the market immediately

After an ongoing investigation, the FDA determined that NDMA level found in tested samples of ranitidine levels increase over time and when medications are stored at a higher-than-normal temperature.   This may result in consumer exposure unacceptable levels of the impurity, NDMA.   Consumers are now advised to stop taking ranitidine medications they are currently using and discard of them in proper fashion.

Zantac – Risks & Important Information

Zantac – Risks & Important Information

Since the summer of 2019, the U.S. Food and Drug Administration (FDA) has been investigating the potential harmful side-effects of the usage of prescription and over-the-counter ranitidine medicines, including the popular heartburn brand, Zantac. On September 13, 2019, the FDA issued a statement alerting the public to their discovery of an impurity called N-nitrosodimethylamine (NDMA) in some ranitidine medicines, including popular over-the-counter heartburn medication, Zantac. NDMA is classified as a probable human carcinogen and a known environmental contaminant.

On November 22, 2019, the FDA alerted health care professionals and patients to multiple voluntary recalls of Zantac (ranitidine) by manufacturers including Sanofi and GlaxoSmithKline. These products are being recalled due to potentially unacceptable levels of NDMA. The FDA has advised drug companies to recall their medicines if sample tests reveal NDMA above the acceptable daily intake levels.

Zantac – Risks & Important Information

Complications and Symptoms

Complications and Symptoms

Symptoms of NDMA overexposure:

-Headache
-Fever
-Nausea/vomiting
-Jaundice
-Dizziness

High levels of exposure can cause reduced function of the kidneys and lungs, and involve any of the adverse effects listed below:


Complications/Adverse Effects Associated with usage of Zantac:

-Hepatitis, liver failure
-Nervous system disorders
-Arrhythmia or tachycardia
-Skin rashes and hair loss
-Vitamin B-12 deficiency

Complications and Symptoms

Zantac Lawsuits – What We Know

Zantac Lawsuits – What We Know

Multiple lawsuits have been filed against manufacturers of Zantac. Plaintiffs allege that the drugmakers Sanofi and Boerhinger Ingelheim manufactured, marketed and sold a product they knew or reasonably should have known, was contaminated with a known carcinogen.   Furthermore, plaintiffs accuse the drugmakers of choosing not to disclose the risk of such contamination to consumers or the government.  The lawsuits have alleged that the company knew or should have known that the products had been contaminated with an industrial chemical known to cause cancer.

Your Legal Options

If you or a loved one has been recently diagnosed with any of the above–referenced conditions following the use of Zantac, call Gruber Law Offices. We are working in partnership with a pharmaceutical-focused national, award-winning  law firm. Our team is available 24/7 to discuss your legal options. Call us now for a free and confidential consultation.

Zantac Lawsuits – What We Know

Injured?
Get help now!

Get Started